Hemoperfusion in chronic schizophrenics: a critical report.

Area of Science:

• Neurology
• Psychiatry
• Medical Technology

Background:

• Schizophrenia is a complex chronic mental disorder.
• Current treatments for chronic schizophrenia have limitations.
• Hemoperfusion is an extracorporeal detoxification technique.

Purpose of the Study:

• To evaluate the efficacy of hemoperfusion in treating chronic schizophrenic patients.
• To assess the safety and potential benefits of hemoperfusion for this patient group.

Main Methods:

• Ten patients diagnosed with chronic schizophrenia were enrolled.
• Treatment involved hemoperfusion administered weekly or twice weekly.
• The duration of the treatment course ranged from 6 to 10 weeks.

Main Results:

• Two patients exhibited significant clinical improvement.
• Three patients experienced a worsening of their schizophrenic symptoms.
• The remaining five patients showed no substantial change.

Conclusions:

• Hemoperfusion demonstrated variable and unpredictable effects in chronic schizophrenic patients.
• The findings suggest that hemoperfusion is unlikely to be a generally useful therapeutic option for this condition.
• Further research is needed to identify potential patient subgroups who might benefit or to refine the technique.